MedTrace Logo

Lung Hyperinflation and Response to Pulmonary Vasodilator Therapy

NCT06613321 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 47

Last updated 2024-09-25

No results posted yet for this study

Summary

The goal of this retrospective observational study is to evaluate if lung distension disorders can be a predictive factor of bad response to vasodilator therapy in patients with pulmonary hypertension (PH) associated with chronic obstructive pulmonary disease (COPD).

The study will include all patients from the hospital, followed for pulmonary hypertension associated with COPD under vasodilator therapy between 2015 and 2021.

Conditions

  • Copd
  • Hypertension, Pulmonary
  • Hyperdistention

Interventions

DIAGNOSTIC_TEST

Respiratory function tests before introduction of vasodilator therapy

Respiratory function tests before introduction of vasodilator therapy with evaluation of the RV/TLC ratio.

DIAGNOSTIC_TEST

3 month follow up evaluation of response to treatment.

Follow up of patients at least 3 months after introduction of vasodilator therapy to determine response to treatment or absence of response.

Sponsors & Collaborators

  • Central Hospital, Nancy, France

    lead OTHER

Principal Investigators

  • Ari Chaouat, MD PhD · Université de Lorraine, Département de Pneumologie, CHRU NANCY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-01
Primary Completion
2024-03-25
Completion
2024-03-25

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06613321 on ClinicalTrials.gov